Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ANVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 22.04M
March 31, 2026 16.24M
December 31, 2025 21.08M
September 30, 2025 17.19M
June 30, 2025 21.45M
March 31, 2025 26.74M
December 31, 2024 13.93M
September 30, 2024 14.36M
June 30, 2024 5.046M
March 31, 2024 7.813M
December 31, 2023 10.21M
September 30, 2023 10.22M
June 30, 2023 22.82M
March 31, 2023 25.55M
December 31, 2022 36.02M
September 30, 2022 32.49M
Date Value
June 30, 2022 36.53M
March 31, 2022 43.30M
December 31, 2021 46.00M
September 30, 2021 47.65M
June 30, 2021 49.50M
March 31, 2021 5.965M
December 31, 2020 8.119M
September 30, 2020 9.402M
June 30, 2020 10.20M
March 31, 2020 11.44M
December 31, 2019 1.117M
September 30, 2019 0.3799M
June 30, 2019 0.3005M
March 31, 2019 0.4313M
December 31, 2018 0.051M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics